Selective Janus Kinase 1 Inhibition Is a Promising Therapeutic Approach for Lupus Erythematosus Skin Lesions.
Frontiers in immunology
View this publicationFrontiers in immunology
View this publicationScientific reports
View this publicationPLoS computational biology
View this publicationJournal for immunotherapy of cancer
View this publicationMMW Fortschritte der Medizin
View this publicationJournal of immunology (Baltimore, Md. : 1950)
View this publicationAnnals of the rheumatic diseases
View this publicationBMC neurology
View this publicationBiochemical Society transactions
View this publicationPLoS neglected tropical diseases
View this publication